Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Perioperative Hyperglycemia Management: An UpdateAnesthesiology (Philadelphia), 2017-03, Vol.126 (3), p.547-560 [Peer Reviewed Journal]Copyright © by 2017, the American Society of Anesthesiologists, Inc. Wolters Kluwer Health, Inc. All Rights Reserved. ;ISSN: 0003-3022 ;EISSN: 1528-1175 ;DOI: 10.1097/ALN.0000000000001515 ;PMID: 28121636Full text available |
|
2 |
Material Type: Article
|
Empagliflozin and Progression of Kidney Disease in Type 2 DiabetesThe New England journal of medicine, 2016-11, Vol.375 (18), p.1799 [Peer Reviewed Journal]EISSN: 1533-4406 ;PMID: 27806237Full text available |
|
3 |
Material Type: Article
|
Advances in oral peptide therapeuticsNature reviews. Drug discovery, 2020-04, Vol.19 (4), p.277-289 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2019. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/s41573-019-0053-0 ;PMID: 31848464Full text available |
|
4 |
Material Type: Article
|
Diabetic Kidney Disease: Challenges, Progress, and PossibilitiesClinical journal of the American Society of Nephrology, 2017-12, Vol.12 (12), p.2032-2045 [Peer Reviewed Journal]Copyright © 2017 by the American Society of Nephrology. ;Copyright © 2017 by the American Society of Nephrology 2017 ;ISSN: 1555-9041 ;EISSN: 1555-905X ;DOI: 10.2215/CJN.11491116 ;PMID: 28522654Full text available |
|
5 |
Material Type: Article
|
Caloric Restriction Mimetics against Age-Associated Disease: Targets, Mechanisms, and Therapeutic PotentialCell metabolism, 2019-03, Vol.29 (3), p.592-610 [Peer Reviewed Journal]2019 Elsevier Inc. ;Copyright © 2019 Elsevier Inc. All rights reserved. ;ISSN: 1550-4131 ;ISSN: 1932-7420 ;EISSN: 1932-7420 ;DOI: 10.1016/j.cmet.2019.01.018 ;PMID: 30840912Full text available |
|
6 |
Material Type: Article
|
Type 1 diabetesThe Lancet (British edition), 2018-06, Vol.391 (10138), p.2449-2462 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 16, 2018 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31320-5 ;PMID: 29916386Full text available |
|
7 |
Material Type: Article
|
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 DiabetesCell Metabolism, 2020-06, Vol.31 (6), p.1068-1077.e3 [Peer Reviewed Journal]2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 1550-4131 ;EISSN: 1932-7420 ;DOI: 10.1016/j.cmet.2020.04.021 ;PMID: 32369736Digital Resources/Online E-Resources |
|
8 |
Material Type: Article
|
The mechanisms of action of metforminDiabetologia, 2017-09, Vol.60 (9), p.1577-1585 [Peer Reviewed Journal]The Author(s) 2017 ;Diabetologia is a copyright of Springer, 2017. ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-017-4342-z ;PMID: 28776086Full text available |
|
9 |
Material Type: Article
|
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesThe New England journal of medicine, 2016-03, Vol.374 (11), p.1092-1094 [Peer Reviewed Journal]Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc1600827 ;PMID: 26981940Full text available |
|
10 |
Material Type: Article
|
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetes care, 2018-12, Vol.41 (12), p.2669-2701 [Peer Reviewed Journal]2018 American Diabetes Association and European Association for the Study of Diabetes. ;Copyright American Diabetes Association Dec 1, 2018 ;2018 American Diabetes Association and European Association for the Study of Diabetes. 2018 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dci18-0033 ;PMID: 30291106Full text available |
|
11 |
Material Type: Article
|
Glucagon-like peptide 1 (GLP-1)Molecular metabolism (Germany), 2019-12, Vol.30, p.72-130 [Peer Reviewed Journal]2019 The Authors ;Copyright © 2019 The Authors. Published by Elsevier GmbH.. All rights reserved. ;2019 The Authors 2019 ;ISSN: 2212-8778 ;EISSN: 2212-8778 ;DOI: 10.1016/j.molmet.2019.09.010 ;PMID: 31767182Full text available |
|
12 |
Material Type: Article
|
Cardiovascular disease in diabetes, beyond glucoseCell metabolism, 2021-08, Vol.33 (8), p.1519-1545 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;ISSN: 1550-4131 ;EISSN: 1932-7420 ;DOI: 10.1016/j.cmet.2021.07.001 ;PMID: 34289375Full text available |
|
13 |
Material Type: Article
|
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018Diabetes technology & therapeutics, 2019-02, Vol.21 (2), p.66-72 [Peer Reviewed Journal]Copyright Mary Ann Liebert, Inc. Feb 2019 ;Copyright 2019, Mary Ann Liebert, Inc., publishers 2019 ;ISSN: 1520-9156 ;EISSN: 1557-8593 ;DOI: 10.1089/dia.2018.0384 ;PMID: 30657336Full text available |
|
14 |
Material Type: Article
|
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetologia, 2022-12, Vol.65 (12), p.1925-1966 [Peer Reviewed Journal]American Diabetes Association and the European Association for the Study of Diabetes 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2022. American Diabetes Association and the European Association for the Study of Diabetes. ;American Diabetes Association and the European Association for the Study of Diabetes 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-022-05787-2 ;PMID: 36151309Full text available |
|
15 |
Material Type: Article
|
Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confoundersCancer prevention research (Philadelphia, Pa.), 2014-09, Vol.7 (9), p.867-885 [Peer Reviewed Journal]2014 American Association for Cancer Research. ;ISSN: 1940-6207 ;EISSN: 1940-6215 ;DOI: 10.1158/1940-6207.CAPR-13-0424 ;PMID: 24985407Full text available |
|
16 |
Material Type: Article
|
More on Semaglutide in Early Type 1 Diabetes. ReplyThe New England journal of medicine, 2024-01, Vol.390 (3), p.292-292 [Peer Reviewed Journal]EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2311608 ;PMID: 38231643Full text available |
|
17 |
Material Type: Article
|
New Player in an Old Field? Ecto-F 1 -ATPase in Antidiabetic Actions of HDL in Pancreatic β-CellsArteriosclerosis, thrombosis, and vascular biology, 2024-02, Vol.44 (2), p.419-422 [Peer Reviewed Journal]ISSN: 1079-5642 ;EISSN: 1524-4636 ;DOI: 10.1161/ATVBAHA.123.320426 ;PMID: 38095108Full text available |
|
18 |
Material Type: Article
|
Metformin: From Mechanisms of Action to TherapiesCell metabolism, 2014-12, Vol.20 (6), p.953-966 [Peer Reviewed Journal]2014 Elsevier Inc. ;Copyright © 2014 Elsevier Inc. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1550-4131 ;EISSN: 1932-7420 ;DOI: 10.1016/j.cmet.2014.09.018 ;PMID: 25456737Full text available |
|
19 |
Material Type: Article
|
Metformin: historical overviewDiabetologia, 2017-09, Vol.60 (9), p.1566-1576 [Peer Reviewed Journal]Springer-Verlag Berlin Heidelberg 2017 ;Diabetologia is a copyright of Springer, 2017. ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-017-4318-z ;PMID: 28776081Full text available |
|
20 |
Material Type: Article
|
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trialThe Lancet (British edition), 2021-11, Vol.398 (10313), p.1811-1824 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02188-7 ;PMID: 34672967Full text available |